Mytelmi 20/40

Telmisartan 20mg 0r 40mg Tablets

For 24 hours sustained BP reduction

Treatment of choice in hypertension, metabolic syndrome & at high risk CVD patients
Favourable effects on insulin resistance, lipid levels, left ventricular hypertrophy (LVH) and renal function
Reduces myocardial hypertrophy, endothelial dysfunction and severity of ischemic manifestations
Reduces the risk of CVD and mortality